Advanced search
Publication Cover
Journal of Psychoactive Drugs Volume 15, 1983 - Issue 1-2: The Benzodiazepines. Two Decades of Research and Clinical Experience
Submit an article Journal homepage
23
Views
28
CrossRef citations to date
0
Altmetric
BENZODIAZEPINE ABUSE AND DEPENDENCE

Symptoms of the Barbiturate/Benzodiazepine Withdrawal Syndrome in Healthy Volunteers: Standardized Assessment by a Newly Developed Self-Rating Scale

Walter A. Merz Department of Clinical Research, F. Hoffmann-La Roche, CH-4002 Basel, Switzerland
&
Urs Ballmer Department of Clinical Research, F. Hoffmann-La Roche, CH-4002 Basel, Switzerland
Pages 71-84 | Published online: 19 Jan 2012

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

DavidE. Smith & DonaldR. Wesson. (1983) Benzodiazepine Dependency Syndromes. Journal of Psychoactive Drugs 15:1-2, pages 85-95.
Read now

Articles from other publishers (27)

Debora Dhanya Amarnath & Uma Pricilda Jaidev. (2020) Toward an integrated model of consumer reactance: a literature analysis. Management Review Quarterly 71:1, pages 41-90.
Crossref
Daniela F. Curado, Viviam V. de Barros, Emérita S. Opaleye & Ana Regina Noto. (2020) Psychometric properties of the Benzodiazepine Dependence Self-Report Questionnaire – Portuguese Version (BENDEP-SRQ-PV). Trends in Psychiatry and Psychotherapy 42:4, pages 358-367.
Crossref
Robert S. Mansbach, Kerri A. Schoedel, Jeffrey P. Kittrelle & Edward M. Sellers. (2010) The role of adverse events and related safety data in the pre-market evaluation of drug abuse potential. Drug and Alcohol Dependence 112:3, pages 173-177.
Crossref
Georges Moroz & Graham McClelland. 2005. Clinical Trials of Drugs and Biopharmaceuticals. Clinical Trials of Drugs and Biopharmaceuticals 251 267 .
Richard C Oude Voshaar, Audrey J.J Mol, Wim J.M.J Gorgels, Marinus H.M Breteler, Anton J.L.M van Balkom, Eloy H van de Lisdonk, Cees C Kan & Frans G Zitman. (2003) Cross-validation, predictive validity, and time course of the Benzodiazepine Dependence Self-Report Questionnaire in a benzodiazepine discontinuation trial. Comprehensive Psychiatry 44:3, pages 247-255.
Crossref
Jaap E. Couvée & Frans G. Zitman. (2002) The Benzodiazepine Withdrawal Symptom Questionnaire: psychometric evaluation during a discontinuation program in depressed chronic benzodiazepine users in general practice. Addiction 97:3, pages 337-345.
Crossref
Kenneth L. Lichstein, Britt Ann Peterson, Brant W. Riedel, Melanie K. Means, Michael T. Epperson & R. Neal Aguillard. (2016) Relaxation to Assist Sleep Medication Withdrawal. Behavior Modification 23:3, pages 379-402.
Crossref
C.C Kan, M.H.M Breteler, E.A.Y Timmermans, A.H.G.S van der Ven & F.G Zitman. (1999) Scalability, reliability, and validity of the benzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users. Comprehensive Psychiatry 40:4, pages 283-291.
Crossref
M. Linden, D. Hadler & S. Hofmann. (1997) Randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a new isoindoline derivative (DN-2327) in generalized anxiety. Human Psychopharmacology: Clinical and Experimental 12:5, pages 445-452.
Crossref
Andrew J. Baillie & Richard P. Mattick. (2018) The Benzodiazepine Dependence Questionnaire: Development, Reliability and Validity. British Journal of Psychiatry 169:3, pages 276-281.
Crossref
GB Cassano, A Petracca, C Borghi, S Chiroli, G Didoni & M Garreau. (2020) A randomized, double-blind study of alpidem vs placebo in the prevention and treatment of benzodiazepine withdrawal syndrome. European Psychiatry 11:2, pages 93-99.
Crossref
Roberto Delle Chiaie, Paolo Pancheri, Massimo Casacchia, Paolo Stratta, Giorgio D. Kotzalidis & Marco Zibellini. (1995) Assessment of the Efficacy of Buspirone in Patients Affected by Generalized Anxiety Disorder, Shifting to Buspirone From Prior Treatment with Lorazepam. Journal of Clinical Psychopharmacology 15:1, pages 12-19.
Crossref
Fritz Hohagen, Rosemarie Fritsch Montero, Eric Weiss, Steffi Lis, Ekkehart Schönbrunn, Harald Dressing, Dieter Riemann & Mathias Berger. (1994) Treatment of primary insomnia with trimipramine: An alternative to benzodiazepine hypnotics?. European Archives of Psychiatry and Clinical Neuroscience 244:2, pages 65-72.
Crossref
G.B. Cassano, A. Petracca & B.M. Cesana. (1994) A new scale for the evaluation of benzodiazepine withdrawal symptoms: Sessb. Current Therapeutic Research 55:3, pages 275-289.
Crossref
D. Ladewig. 1994. Therapie von Entzugssyndromen. Therapie von Entzugssyndromen 158 168 .
M Bourin, A Couetoux du Tertre & R Payeur. (2020) Evaluation of safety and side effects in the process of anti-anxiety drug development *. European Psychiatry 8:6, pages 285-291.
Crossref
P.M. Brenner, B. Wolf, Th. Rechlin, G. Kauert, E. Rüther & H. Hippius. (1991) Benzodiazepine dependence: detoxification under standardized conditions. Drug and Alcohol Dependence 29:2, pages 195-204.
Crossref
C. Gudex. (1991) Adverse effects of Benzodiazepines. Social Science & Medicine 33:5, pages 587-596.
Crossref
Peter Tyrer, Siobhan Murphy & Patrick Riley. (1990) The benzodiazepine withdrawal symptom questionnaire. Journal of Affective Disorders 19:1, pages 53-61.
Crossref
David J. Nutt. (1990) The pharmacology of human anxiety. Pharmacology & Therapeutics 47:2, pages 233-266.
Crossref
David E. Smith & Mim J. Landry. (1990) Benzodiazepine dependency discontinuation: Focus on the chemical dependency detoxification setting and benzodiazepine-polydrug abuse. Journal of Psychiatric Research 24, pages 145-156.
Crossref
G. R. McClelland & P. J. Summerfield. 1990. Early Phase Drug Evaluation in Man. Early Phase Drug Evaluation in Man 421 432 .
F. Kräupl Taylor. (2018) The Damnation of Benzodiazepines. British Journal of Psychiatry 154:5, pages 697-704.
Crossref
B. Hanin & J. Marks. (2020) Dépendance aux benzodiazépines et syndrome de sevrage. Revue de la littérature. Psychiatry and Psychobiology 3:5, pages 347-364.
Crossref
E. K. Rodrigo & P. Williams. (2009) Frequency of self-reported ‘anxiolytic withdrawal’ symptoms in a group of female students experiencing anxiety. Psychological Medicine 16:2, pages 467-472.
Crossref
David Nutt. (1986) Benzodiazepine dependence in the clinic: reason for anxiety?. Trends in Pharmacological Sciences 7, pages 457-460.
Crossref
J. Marks. 1986. The Future of Predictive Safety Evaluation. The Future of Predictive Safety Evaluation 153 167 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.